WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access ...
MISSISSAUGA, Ontario, September 16, 2025--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced ...
The management of many medical and surgical conditions often involves long-term infusion of intravenous fluids, broad-spectrum antibiotics, chemotherapeutic agents for cancer, critical care therapies, ...
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs) Peer-reviewed study ...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of results from a peer-reviewed clinical ...
Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024 MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback